Skip to main content
Human Gene PIP5K1C (ENST00000335312.8) from GENCODE V50
  Description: phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant 2 (from RefSeq NM_012398.3)
Gencode Transcript: ENST00000335312.8
Gencode Gene: ENSG00000186111.13
Transcript (Including UTRs)
   Position: hg38 chr19:3,630,183-3,700,468 Size: 70,286 Total Exon Count: 18 Strand: -
Coding Region
   Position: hg38 chr19:3,633,167-3,700,390 Size: 67,224 Coding Exon Count: 18 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
RNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesMethods
Data last updated at UCSC: 2026-07-12 09:30:09

-  Comments and Description Text from UniProtKB
  ID: PI51C_HUMAN
DESCRIPTION: RecName: Full=Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma; Short=PIP5K1-gamma; Short=PtdIns(4)P-5-kinase 1 gamma; EC=2.7.1.68; AltName: Full=Phosphatidylinositol 4-phosphate 5-kinase type I gamma; Short=PIP5KIgamma;
FUNCTION: Catalyzes the phosphorylation of phosphatidylinositol 4- phosphate (PtdIns4P) to form phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). PtdIns(4,5)P2 is involved in a variety of cellular processes and is the substrate to form phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3), another second messenger. The majority of PtdIns(4,5)P2 is thought to occur via type I phosphatidylinositol 4-phosphate 5-kinases given the abundance of PtdIns4P. Participates in a variety of cellular processes such as vesicle mediated transport, cell adhesion, cell polarization and cell migration. Together with PIP5K1A is required for phagocytosis, but they regulate different types of actin remodeling at sequential steps. Promotes particle attachment by generating the pool of PtdIns(4,5)P2 that induces controlled actin depolymerization to facilitate Fc-gamma-R clustering. Mediates RAC1-dependent reorganization of actin filaments. Required for synaptic vesicle transport. Controls the plasma membrane pool of PtdIns(4,5)P2 implicated in synaptic vesicle endocytosis and exocytosis. Plays a role in endocytosis mediated by clathrin and AP-2 (adaptor protein complex 2). Required for clathrin-coated pits assembly at the synapse. Participates in cell junction assembly. Modulates adherens junctions formation by facilitating CDH1 trafficking. Required for focal adhesion dynamics. Modulates the targeting of talins (TLN1 and TLN2) to the plasma membrane and their efficient assembly into focal adhesions. Regulates the interaction between talins (TLN1 and TLN2) and beta-integrins. Required for uropodium formation and retraction of the cell rear during directed migration. Has a role in growth factor- stimulated directional cell migration and adhesion. Required for talin assembly into nascent adhesions forming at the leading edge toward the direction of the growth factor. Negative regulator of T-cell activation and adhesion. Negatively regulates integrin alpha-L/beta-2 (LFA-1) polarization and adhesion induced by T-cell receptor. Together with PIP5K1A have a role during embryogenesis and together with PIP5K1B may have a role immediately after birth.
CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 4- phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate.
ENZYME REGULATION: Activated by interaction with TLN2.
SUBUNIT: Interacts with TLN1 (By similarity). Interacts with TLN2; interaction stimulates lipid kinase activity. May compete with beta-integrins for the same binding site on TLN1 and TLN2. Interacts with ARF6. Interacts with AP2B1. Interacts with AP2M1; phosphorylation of PIP5K1C by CSK disrupts the interaction; clathrin competes with PIP5K1C (By similarity). Interacts with CDH1. Interacts with CSK (By similarity). Interacts with PLCG1; interaction is abolished upon EGF stimulation (By similarity).
SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein; Cytoplasmic side. Endomembrane system. Cytoplasm. Cell junction, focal adhesion. Cell junction, adherens junction. Cell projection, ruffle membrane. Cell projection, phagocytic cup. Cell projection, uropodium. Note=Detected in plasma membrane invaginations. Isoform 3 is detected in intracellular vesicle-like structures.
SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Nucleus.
TISSUE SPECIFICITY: Isoform 1 is strongly expressed in brain and also detected in heart and lung. Isoform 2 is strongly expressed in pancreas and liver and in lesser quantities in brain, heart, lung and kidney. Isoform 3 is detected in large amounts in heart and large intestine, is also present in lung, pancreas and thyroid, and to a lesser extent in brain, stomach and kidney.
PTM: Phosphorylation on Ser-650 negatively regulates binding to TLN2 and is strongly stimulated in mitosis. Phosphorylation on Tyr-649 is necessary for targeting to focal adhesions. Phosphorylation on Ser-650 and Tyr-649 are mutually exclusive. Phosphorylated by SYK and CSK (By similarity). Tyrosine phosphorylation is enhanced by PTK2 signaling. Phosphorylated at Tyr-639 upon EGF stimulation. Some studies suggest that phosphorylation on Tyr-649 enhances binding to tailins (TLN1 and TLN2). According to PubMed:15738269 phosphorylation at Tyr-649 does not directly enhance binding to tailins (TLN1 and TLN2) but may act indirectly by inhibiting phosphorylation at Ser-650.
PTM: Acetylation at Lys-265 and Lys-268 seems to decrease lipid kinase activity. Deacetylation of these sites by SIRT1 positively regulates the exocytosis of TSH-containing granules from pituitary cells.
DISEASE: Defects in PIP5K1C are the cause of lethal congenital contracture syndrome type 3 (LCCS3) [MIM:611369]; also known as multiple contractural syndrome Israeli Bedouin type B. LCCS is an autosomal recessive disorder characterized by early fetal hydrops and akinesia, the Pena-Shokeir phenotype, specific neuropathology with degeneration of anterior horn neurons and extreme skeletal muscle atrophy. LCCS3 patients present at birth with severe multiple joint contractures with severe muscle wasting and atrophy, mainly in the legs. LCCS3 can be distinguished from the original LCCS by the absence of hydrops, fractures, and multiple pterygia.
SIMILARITY: Contains 1 PIPK domain.
SEQUENCE CAUTION: Sequence=BAA25515.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: PIP5K1C
Diseases sorted by gene-association score: lethal congenital contractural syndrome 3* (1550), lethal congenital contracture syndrome (19), neurogenic bladder (14), lethal congenital contractural syndrome 2 (13), lethal congenital contracture syndrome 1 (12)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 78.15 RPKM in Brain - Cerebellum
Total median expression: 1006.64 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
 
Expression ratio colors:

GNF Expression Atlas 2 Data from U133A and GNF1H Chips

      
      
      
     
    
     
Ratios
      
      
      
     
    
     
Absolute
      
       
      
      
     
    
Ratios
      
       
      
      
     
    
Absolute
   
     
     
Ratios
   
     
     
Absolute

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -50.2078-0.644 Picture PostScript Text
3' UTR -1263.602984-0.423 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR023610 - PInositol-4-P-5-kinase
IPR002498 - PInositol-4-P-5-kinase_core
IPR016034 - PInositol-4P-5-kinase_core_sub

Pfam Domains:
PF01504 - Phosphatidylinositol-4-phosphate 5-Kinase

Protein Data Bank (PDB) 3-D Structure
MuPIT help
3H1Z - X-ray 3H85 - X-ray


ModBase Predicted Comparative 3D Structure on O60331
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
Genome BrowserGenome BrowserGenome BrowserNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
MGIRGDEnsembl   
Protein SequenceProtein SequenceProtein Sequence   
AlignmentAlignmentAlignment   

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000166 nucleotide binding
GO:0005515 protein binding
GO:0005524 ATP binding
GO:0016301 kinase activity
GO:0016307 phosphatidylinositol phosphate kinase activity
GO:0016308 1-phosphatidylinositol-4-phosphate 5-kinase activity
GO:0016740 transferase activity
GO:0052811 1-phosphatidylinositol-3-phosphate 4-kinase activity
GO:0052812 phosphatidylinositol-3,4-bisphosphate 5-kinase activity

Biological Process:
GO:0006661 phosphatidylinositol biosynthetic process
GO:0006887 exocytosis
GO:0006897 endocytosis
GO:0006909 phagocytosis
GO:0006935 chemotaxis
GO:0007155 cell adhesion
GO:0014066 regulation of phosphatidylinositol 3-kinase signaling
GO:0016079 synaptic vesicle exocytosis
GO:0016310 phosphorylation
GO:0030036 actin cytoskeleton organization
GO:0030593 neutrophil chemotaxis
GO:0034333 adherens junction assembly
GO:0046488 phosphatidylinositol metabolic process
GO:0046854 phosphatidylinositol phosphorylation
GO:0048488 synaptic vesicle endocytosis
GO:0061024 membrane organization
GO:0072583 clathrin-dependent endocytosis
GO:0098609 cell-cell adhesion

Cellular Component:
GO:0001891 phagocytic cup
GO:0001931 uropod
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0005886 plasma membrane
GO:0005912 adherens junction
GO:0005925 focal adhesion
GO:0010008 endosome membrane
GO:0012505 endomembrane system
GO:0016020 membrane
GO:0030054 cell junction
GO:0032587 ruffle membrane
GO:0042995 cell projection
GO:0045202 synapse
GO:0098793 presynapse


-  Descriptions from all associated GenBank mRNAs
  LF384671 - JP 2014500723-A/192174: Polycomb-Associated Non-Coding RNAs.
MA620248 - JP 2018138019-A/192174: Polycomb-Associated Non-Coding RNAs.
AB011161 - Homo sapiens KIAA0589 mRNA for KIAA0589 protein.
AK315912 - Homo sapiens cDNA, FLJ78811 complete cds, highly similar to Phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (EC 2.7.1.68).
AK301309 - Homo sapiens cDNA FLJ61177 complete cds, highly similar to Phosphatidylinositol-4-phosphate 5-kinasetype-1 gamma (EC 2.7.1.68).
AB385354 - Synthetic construct DNA, clone: pF1KA0589, Homo sapiens PIP5K1C gene for phosphatidylinositol-4-phosphate 5-kinase, type I, gamma, complete cds, without stop codon, in Flexi system.
BC167798 - Synthetic construct Homo sapiens clone IMAGE:100068188, MGC:195805 phosphatidylinositol-4-phosphate 5-kinase, type I, gamma (PIP5K1C) mRNA, encodes complete protein.
FJ965536 - Homo sapiens phosphatidylinositol 4-phosphate 5-kinase type I gamma splice variant 700 (PIP5K1C) mRNA, complete cds, alternatively spliced.
FJ965537 - Homo sapiens phosphatidylinositol 4-phosphate 5-kinase type I gamma splice variant 707 (PIP5K1C) mRNA, complete cds, alternatively spliced.
BC011138 - Homo sapiens phosphatidylinositol-4-phosphate 5-kinase, type I, gamma, mRNA (cDNA clone IMAGE:3448753).
BC004149 - Homo sapiens phosphatidylinositol-4-phosphate 5-kinase, type I, gamma, mRNA (cDNA clone IMAGE:2819393), partial cds.
JD360420 - Sequence 341444 from Patent EP1572962.
JD379486 - Sequence 360510 from Patent EP1572962.
JD464577 - Sequence 445601 from Patent EP1572962.
JD193829 - Sequence 174853 from Patent EP1572962.
JD065851 - Sequence 46875 from Patent EP1572962.
JD098289 - Sequence 79313 from Patent EP1572962.
JD525098 - Sequence 506122 from Patent EP1572962.
JD229333 - Sequence 210357 from Patent EP1572962.
JD543081 - Sequence 524105 from Patent EP1572962.
JD326537 - Sequence 307561 from Patent EP1572962.
JD053744 - Sequence 34768 from Patent EP1572962.
JD438950 - Sequence 419974 from Patent EP1572962.
JD264199 - Sequence 245223 from Patent EP1572962.
JD138990 - Sequence 120014 from Patent EP1572962.
JD305624 - Sequence 286648 from Patent EP1572962.
JD498838 - Sequence 479862 from Patent EP1572962.
JD065143 - Sequence 46167 from Patent EP1572962.
JD392729 - Sequence 373753 from Patent EP1572962.
JD180638 - Sequence 161662 from Patent EP1572962.
JD364918 - Sequence 345942 from Patent EP1572962.
JD189066 - Sequence 170090 from Patent EP1572962.
JD123564 - Sequence 104588 from Patent EP1572962.
JD471737 - Sequence 452761 from Patent EP1572962.
JD390128 - Sequence 371152 from Patent EP1572962.
JD405734 - Sequence 386758 from Patent EP1572962.
JD274810 - Sequence 255834 from Patent EP1572962.
JD395584 - Sequence 376608 from Patent EP1572962.
JD414161 - Sequence 395185 from Patent EP1572962.
JD177013 - Sequence 158037 from Patent EP1572962.
JD191434 - Sequence 172458 from Patent EP1572962.
JD461545 - Sequence 442569 from Patent EP1572962.
JD103322 - Sequence 84346 from Patent EP1572962.
JD400822 - Sequence 381846 from Patent EP1572962.
JD404043 - Sequence 385067 from Patent EP1572962.
JD281518 - Sequence 262542 from Patent EP1572962.
JD256426 - Sequence 237450 from Patent EP1572962.
JD540852 - Sequence 521876 from Patent EP1572962.
JD157592 - Sequence 138616 from Patent EP1572962.
JD215327 - Sequence 196351 from Patent EP1572962.
JD335212 - Sequence 316236 from Patent EP1572962.
JD347319 - Sequence 328343 from Patent EP1572962.
JD385300 - Sequence 366324 from Patent EP1572962.
JD252681 - Sequence 233705 from Patent EP1572962.
DQ592399 - Homo sapiens piRNA piR-59511, complete sequence.
JD098473 - Sequence 79497 from Patent EP1572962.
JD472014 - Sequence 453038 from Patent EP1572962.
JD251626 - Sequence 232650 from Patent EP1572962.
JD300256 - Sequence 281280 from Patent EP1572962.
JD337838 - Sequence 318862 from Patent EP1572962.
JD118961 - Sequence 99985 from Patent EP1572962.
JD406279 - Sequence 387303 from Patent EP1572962.
JD498718 - Sequence 479742 from Patent EP1572962.
JD276806 - Sequence 257830 from Patent EP1572962.
JD125954 - Sequence 106978 from Patent EP1572962.
JD565904 - Sequence 546928 from Patent EP1572962.
JD432735 - Sequence 413759 from Patent EP1572962.
JD443205 - Sequence 424229 from Patent EP1572962.
JD368932 - Sequence 349956 from Patent EP1572962.
JD188429 - Sequence 169453 from Patent EP1572962.
JD048000 - Sequence 29024 from Patent EP1572962.
JD137600 - Sequence 118624 from Patent EP1572962.
JD128718 - Sequence 109742 from Patent EP1572962.
JD115883 - Sequence 96907 from Patent EP1572962.
JD093978 - Sequence 75002 from Patent EP1572962.
DQ585395 - Homo sapiens piRNA piR-52507, complete sequence.
KX404988 - Homo sapiens isolate PIP5KC_exon_exclusion_F circular RNA circRNA, complete sequence.
KX404989 - Homo sapiens isolate PIP5KC_exon_inclusion_F circular RNA circRNA, complete sequence.
JD399377 - Sequence 380401 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa00562 - Inositol phosphate metabolism
hsa01100 - Metabolic pathways
hsa04070 - Phosphatidylinositol signaling system
hsa04144 - Endocytosis
hsa04510 - Focal adhesion
hsa04666 - Fc gamma R-mediated phagocytosis
hsa04810 - Regulation of actin cytoskeleton

BioCyc Knowledge Library
PWY-6351 - D-myo-inositol (1,4,5)-trisphosphate biosynthesis
PWY-6352 - 3-phosphoinositide biosynthesis
PWY-6371 - superpathway of inositol phosphate compounds

Reactome (by CSHL, EBI, and GO)

Protein O60331 (Reactome details) participates in the following event(s):

R-HSA-399936 Inhibition of integrin activation by sequestering PIP5KIgamma
R-HSA-8868066 PIP5K1C phosphorylates PI(4)P to PI(4,5)P2
R-HSA-1676082 PI4P is phosphorylated to PI(4,5)P2 by PIP5K1A-C at the plasma membrane
R-HSA-1675773 PI(3,4)P2 is phosphorylated to PI(3,4,5)P3 by PIP5K1A-C at the plasma membrane
R-HSA-1676145 PI3P is phosphorylated to PI(3,4)P2 by PIP4K2/5K1 at the plasma membrane
R-HSA-399955 SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
R-HSA-8856828 Clathrin-mediated endocytosis
R-HSA-373755 Semaphorin interactions
R-HSA-1660499 Synthesis of PIPs at the plasma membrane
R-HSA-6811558 PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
R-HSA-199991 Membrane Trafficking
R-HSA-422475 Axon guidance
R-HSA-1483255 PI Metabolism
R-HSA-199418 Negative regulation of the PI3K/AKT network
R-HSA-5653656 Vesicle-mediated transport
R-HSA-1266738 Developmental Biology
R-HSA-1483257 Phospholipid metabolism
R-HSA-1257604 PIP3 activates AKT signaling
R-HSA-556833 Metabolism of lipids
R-HSA-9006925 Intracellular signaling by second messengers
R-HSA-1430728 Metabolism
R-HSA-162582 Signal Transduction

-  Other Names for This Gene
  Alternate Gene Symbols: B7Z9E7, C6GIJ7, C6GIJ8, ENST00000335312.1, ENST00000335312.2, ENST00000335312.3, ENST00000335312.4, ENST00000335312.5, ENST00000335312.6, ENST00000335312.7, KIAA0589, NM_012398, O60331, PI51C_HUMAN, PIP5K1C , Q7LE07, uc002lyj.1, uc002lyj.2, uc002lyj.3, uc002lyj.4
UCSC ID: ENST00000335312.8
RefSeq Accession: NM_012398.3
Protein: O60331 (aka PI51C_HUMAN)
CCDS: CCDS32872.1, CCDS56074.1

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.